Author/Authors :
Kazemiha, Milad Department of Anatomy - School of Medicine - Iran University of Medical Sciences, Tehran , Sarveazad, Arash Iran University of Medical Sciences, Tehran , Moradi, Fatemeh Department of Anatomy - School of Medicine - Iran University of Medical Sciences, Tehran , Ramezanpour, Farnaz Department of Anatomy - School of Medicine - Iran University of Medical Sciences, Tehran , Vosoogh, Mehran Graduate , Doshmanziari, Maryam Department of Anatomy - School of Medicine - Iran University of Medical Sciences, Tehran , Shariatpanahi, Marjan Department of Toxicology and Pharmacology - School of Pharmacy - International Campus - Iran University of Medical Sciences, Tehran , Eftekharzadeh, Mina Department of Anatomy - School of Medicine - Iran University of Medical Sciences, Tehran
Abstract :
Background: Alzheimer’s disease (AD) is a progressive cognitive disorder that is generally age-related. Although there has been
great research focusing on this disease, there is still a lack of reliable therapeutic methods. Amyloid- (A) peptide has a critical
function in neuropathology of AD. Stem cell therapy provides treatment by improving the neuronal system in neurodegenerative
disorders. Human adipose-derived stem cells (hADSCs) are the most appropriate sources of stem cells due to their safety, high proliferative
potential, and easy isolation.
Objectives: The present studywas designed to evaluate the histologicalandbehavioral alterations after intravenous administration
of hADSCs in the AD rat model.
Methods: In this study, 32 male rats were used in four groups, as follows: control, sham, AD rat model, and hADSCs-treated group.
We used MorrisWater Maze (MWM) for evaluating behavioral changes and Nissl staining for determining the histological studies.
Results: In this study, the AD model was confirmed by behavioral and histological analysis. Behavioral results showed that the
spatial memory improved after hADSCs injection in the AD rat model while the time spent in the target quadrant was significantly
higher in the hADSCs-treated group than in the AD rat model group. On the other hand, the number of dead cells significantly
decreased in the hADSCs-treated group as analyzed by Nissl staining.
Conclusions: Our findings revealed that hADSCs could transfer into the brain and improve memory and neuronal damage in the
AD rat model.